Agilent Technologies is a diagnostic & research company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker A on the NYSE exchange.
Agilent Technologies stock last closed at $123.87, down 1.54% from the previous day, and has decreased 8.38% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.14 percentage points. Agilent Technologies stock is currently +28.46% from its 52-week low of $96.43, and -22.71% from its 52-week high of $160.27.
There are currently 283.5M shares of A outstanding. The market cap of A is $35.12B. In the last 24 hours, 1.69M A shares were traded.
You need a brokerage account in order to access the NYSE market and buy A shares.
Based on our analysis, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, you'll need to fill out some personal details so you can invest in A today.
Now that you have created your account on the best stock buying app, you need to deposit funds:
Check out the walkthrough below for more details depositing funds into your brokerage account.
Once you have identified the best place to buy Agilent Technologies stock, it's critical to evaluate their stock before you invest, so you actually understand the risk and upside.
WallStreetZen was created to help average investors do more accurate fundamental analysis.
You can see all of the due diligence checks on A's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge A's true value.
Using relative valuations ratios:
You can access more valuation analysis on A's stock here.
Out of 13 Wall Street analysts who give recommendations on A, the consensus analyst rating on Agilent Technologies is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
Patrick B Donnelly, a top 20% analyst from Citigroup maintains A with a strong buy rating and raises their A price target from $165.00 to $185.00, on Nov 25, 2025.
Dan Leonard, a top 13% analyst from UBS maintains A with a strong buy rating and raises their A price target from $170.00 to $180.00, on Nov 25, 2025.
UBS's Dan Leonard raised their price target on Agilent Technologies (NYSE: A) by 5.9% from $170 to $180 on 2025/11/25. The analyst maintained their Strong Buy rating on the stock.
Agilent Technologies reported its Q4 and FY 2025 earnings.
Following the quarter's strong performance and management's in-line FY 2026 guidance, Leonard said they revised their model and hiked their price target.
Agilent Technologies reported:
For Q4 2025:
For FY 2025:
Management guided:
For Q1 2026:
For FY 2026:
President & CEO Padraig McDonnell commented: “We enter FY 2026 with confidence and momentum.
“Agilent is uniquely positioned to lead in life sciences and diagnostics for years to come.
"Our progress this year reflects innovation built on a customer-focused approach that creates real value and extraordinary customer intimacy through a unified commercial organization that delivers a seamless end-to-end experience.
“Powered by our expanded Ignite Operating System, these strengths continue to unlock operating efficiencies, fuel innovation, enhance commercial execution, and create long-term value for customers and shareholders.”
Brandon Couillard, a bottom 12% analyst from Wells Fargo maintains A with a strong buy rating and raises their A price target from $150.00 to $175.00, on Nov 25, 2025.
Casey Woodring, a bottom 3% analyst from JP Morgan maintains A with a strong buy rating and raises their A price target from $165.00 to $180.00, on Nov 25, 2025.
Catherine Schulte, a top 14% analyst from Baird maintains A with a buy rating and raises their A price target from $142.00 to $165.00, on Nov 25, 2025.
You can dig deeper into what analysts are saying on the Agilent Technologies stock forecast page.
Last year, A earnings were $1.30B. During the past five year, A's earnings have gone up by 14.52% per year. This was faster than the Diagnostics & Research industry average of 6.68%.
Last year, A revenue was $6.95B. During the last 5 year, A's revenue has increased by 5.41% per year. This was slower than the Diagnostics & Research industry average of 9.25%.
Dig into A's earnings and revenue performance here.
Over the past year, executives and large shareholders at A have sold more shares than they have bought.
Mikael Dolsten, Director of A, was the latest A insider to sell. They sold $389,511.20 worth of A shares on Dec 1, 2025.
Get more info about who owns A shares here.
Agilent Technologies pays a dividend of 0.81%, compared to the Diagnostics & Research industry's average dividend yield of 0.78%. If you owned $1,000 worth of A stock, you would have received $8.06 last year.
Agilent Technologies dividend payments have consistently grown over the past decade and have remained stable.
Get more analysis about Agilent Technologies dividend yield and history here.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two main options:
Press the Open Trade button and eToro will execute your order.
If you require additional info about buying stocks on eToro, watch the how to video below:
Now that you own some A shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to track your A stock.
To reiterate, here are the 6 steps to buy stock in Agilent Technologies:
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Agilent Technologies, create a watchlist on WallStreetZen today.